We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22B
AUM Growth
-$123M
Cap. Flow
-$1.19B
Cap. Flow %
-5.42%
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$62M
2
UBS icon
UBS Group
UBS
+$49.7M
3
APD icon
Air Products & Chemicals
APD
+$47.3M
4
T icon
AT&T
T
+$44.6M
5
LRCX icon
Lam Research
LRCX
+$39.6M

Top Sells

Rank Stock Value
1
HPE icon
Hewlett Packard
HPE
+$61.6M
2
HCA icon
HCA Healthcare
HCA
+$50.8M
3
GEN icon
Gen Digital
GEN
+$50.7M
4
BAX icon
Baxter International
BAX
+$50.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$49.1M

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 16.24%
3 Financials 11.47%
4 Consumer Discretionary 9.38%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIFS icon
976
Hingham Institution for Saving
HIFS
$624M
$677K ﹤0.01%
3,719
SUNS
977
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$677K ﹤0.01%
40,469
MEI icon
978
Methode Electronics
MEI
$458M
$672K ﹤0.01%
16,319
+1,000
+7% +$41.7K
IJH icon
979
iShares Core S&P Mid-Cap ETF
IJH
$121B
$671K ﹤0.01%
19,275
OSB
980
DELISTED
Norbord Inc.
OSB
$667K ﹤0.01%
21,400
-7,500
-26% -$222K
VNO icon
981
Vornado Realty Trust
VNO
$7.65B
$666K ﹤0.01%
+8,777
New +$680K
RBCAA icon
982
Republic Bancorp
RBCAA
$1.96B
$665K ﹤0.01%
18,615
FHN icon
983
First Horizon
FHN
$12.2B
$664K ﹤0.01%
38,100
-21,200
-36% -$377K
IYE icon
984
iShares US Energy ETF
IYE
$1.72B
$662K ﹤0.01%
18,650
-3,410
-15% -$126K
DOC icon
985
Healthpeak Properties
DOC
$15.5B
$656K ﹤0.01%
20,519
+9,587
+88% +$304K
GLRE icon
986
Greenlight Captial
GLRE
$579M
$643K ﹤0.01%
30,751
+13,800
+81% +$288K
CDXS icon
987
Codexis
CDXS
$158M
$642K ﹤0.01%
117,770
CTS icon
988
CTS Corp
CTS
$1.76B
$641K ﹤0.01%
29,662
PKBK icon
989
Parke Bancorp
PKBK
$397M
$632K ﹤0.01%
34,156
CIVB icon
990
Civista Bancshares
CIVB
$608M
$628K ﹤0.01%
30,094
LUMN icon
991
Lumen
LUMN
$6.43B
$622K ﹤0.01%
26,034
-105,000
-80% -$2.64M
TSE
992
DELISTED
Trinseo
TSE
$619K ﹤0.01%
9,000
-11,500
-56% -$752K
GD icon
993
General Dynamics
GD
$103B
$612K ﹤0.01%
3,087
TEN
994
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$607K ﹤0.01%
10,500
-7,900
-43% -$456K
ZEUS
995
DELISTED
Olympic Steel
ZEUS
$600K ﹤0.01%
30,800
-1,800
-6% -$33K
NLY icon
996
Annaly Capital Management
NLY
$17.3B
$598K ﹤0.01%
12,420
+5,475
+79% +$258K
FCNCA icon
997
First Citizens BancShares
FCNCA
$24.7B
$596K ﹤0.01%
1,600
-1,800
-53% -$622K
IPG
998
DELISTED
Interpublic Group of Companies
IPG
$591K ﹤0.01%
24,030
-59,500
-71% -$1.45M
FONR
999
DELISTED
Fonar
FONR
$585K ﹤0.01%
21,080
-4,300
-17% -$98.7K
LULU icon
1000
lululemon athletica
LULU
$13.5B
$584K ﹤0.01%
9,790
-339
-3% -$17.6K

Similar funds

Axa's Q2 2017 Portfolio in Review

As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Element Solutions worth $22.3M.

  • Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
  • Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
  • Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
  • Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
  • Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
  • Axa opened 101 new positions and closed 125 in Q2 2017.
  • Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.

Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.